ZOLA P. HOROVITZ, PH.D.

Selected for the Distinguished Alumni Award in 1983, Zola Horovitz worked 35-years of his pharmacy career at Squibb Corporation in New Jersey. Horovitz’s work encompassed several areas of pharmacy–research, business development and licensing. Between 1967 and 1989, he served in various positions including vice president for Research, vice president for Development and vice president for Licensing and Commercial Development. In 1989, Squibb Corporation merged with Bristol-Meyers and Horovitz served as vice president for Licensing and Commercial Development until he retired in 1994. Horovitz believes that a pharmacy education provides a "great background for a number of areas." When he entered the University of Pittsburgh School of Pharmacy, Horovitz had not decided on a career. He chose the study of pharmacy as a way to obtain a "good solid liberal arts and scientific background." Horovitz’s decision to attend graduate school was influenced by Professor Joseph Buckley, who built an excellent pharmacology department. After receiving an M.S. from the University of Pittsburgh in 1958, Horovitz continued his education at the Veteran’s Administrative Hospital. There, he pursued his interest in the central nervous system, which led him to psychiatric research.


		Selected for the Distinguished Alumni Award in 1983, Zola Horovitz worked 35-years of his pharmacy career at Squibb Corporation in New Jersey. Horovitz’s work encompassed several areas of pharmacy–research, business development and licensing. Between 1967 and 1989, he served in various positions including vice president for Research, vice president for Development and vice president for Licensing and Commercial Development. In 1989, Squibb Corporation merged with Bristol-Meyers and Horovitz served as vice president for Licensing and Commercial Development until he retired in 1994. Horovitz believes that a pharmacy education provides a "great background for a number of areas." When he entered the University of Pittsburgh School of Pharmacy, Horovitz had not decided on a career. He chose the study of pharmacy as a way to obtain a "good solid liberal arts and scientific background." Horovitz’s decision to attend graduate school was influenced by Professor Joseph Buckley, who built an excellent pharmacology department. After receiving an M.S. from the University of Pittsburgh in 1958, Horovitz continued his education at the Veteran’s Administrative Hospital. There, he pursued his interest in the central nervous system, which led him to psychiatric research.		Horovitz was awarded a Ph.D. from the University of Pittsburgh in 1960. On account of his research on antidepressants and neurotransmitters, Horovitz was awarded the prestigious AE Bennett Neuropsychiatric Research Award--the first person from the pharmaceutical industry to receive this award. In 1967, when Horovitz was director of Squibb’s Pharmacology Research, he headed the group that was responsible for research on angiotensin converting enzyme inhibitors to lower blood pressure. This group created the first ACE Inhibitor, Captopril, for which they received the American Heart Association’s Discoverer’s Award. Horovitz has authored more than 50 scientific publications and books, served as director on 14 boards, and served on Princeton University’s Scientific Advisory Council. From his first job at a neighborhood drug store in Squirrel Hill (Pittsburgh) to vice president of a major pharmaceutical company, Horovitz has enjoyed tremendous success in pharmacy and he advises pharmacy graduates to consider employment in the pharmaceutical industry. Between golf, reading, and family, Horovitz continues to serve as a consultant to the pharmaceutical and biotechnology industry.


	ZOLA P. HOROVITZ, PH.D.